000 | 01202 a2200325 4500 | ||
---|---|---|---|
005 | 20250513211133.0 | ||
264 | 0 | _c20000531 | |
008 | 200005s 0 0 eng d | ||
022 | _a0090-3493 | ||
024 | 7 |
_a10.1097/00003246-200004001-00012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbraham, E | |
245 | 0 | 0 |
_aNF-kappaB activation. _h[electronic resource] |
260 |
_bCritical care medicine _cApr 2000 |
||
300 |
_aN100-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aActivation Analysis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xphysiology |
650 | 0 | 4 |
_aCytokines _xphysiology |
650 | 0 | 4 | _aGene Targeting |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aRespiratory Distress Syndrome _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xgenetics |
650 | 0 | 4 |
_aTranscription Factors _xphysiology |
773 | 0 |
_tCritical care medicine _gvol. 28 _gno. 4 Suppl _gp. N100-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-200004001-00012 _zAvailable from publisher's website |
999 |
_c10759192 _d10759192 |